Tandem Diabetes Care, Inc. (TNDM)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-06) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-05-07) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-02-19) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-06) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-06) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-04-30) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-02-26) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-06) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-01) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-02) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-02-21) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-01) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Audit Information | — |
|
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations and Comprehensive Income (loss) | ||
| Consolidated Statements of Operations and Comprehensive Loss | ||
| Consolidated Statements of Stockholders Equity | ||
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Cash Flows (P) | ||
| Notes | ||
| Acquisitions | ||
| Business Segment and Geographic Information | ||
| Commitments and Contingencies | ||
| Composition of Certain Financial Statement Items | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Debt | ||
| Derivatives | ||
| Employee Benefits | ||
| Fair Value Measurements | ||
| Fourth Quarter Financial Data (unaudited) | — |
|
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Leases | ||
| Organization and Basis of Presentation | ||
| Pay Vs Performance Disclosure | ||
| Short-term Investments | ||
| Stockholders' Equity | ||
| Subsequent Event | — |
|
| Summary of Significant Accounting Policies | ||